You watched
Dear buyers! Unfortunately, we are currently unable to accept the application to Canada and are revoking the license. Keep an eye on the site to see if there are any updates from Canada.
Catalog
Client
Currency:
Contacts
Our location:
Ternopil city
Contacts
E-mail
We are on social networks
Go to contacts
0 0
Catalog
Main page
Viewed
18
Wishlist
0
Compare
0
Contacts

Betahistine-KV tablets 8 mg No. 30

SKU: an-1047035
0
All about product
Description
Specification
Reviews 0
Questions0
new
Betahistine-KV tablets 8 mg No. 30
In Stock
173.85 грн.
Active ingredient:Betahistine dihydrochloride
Adults:Can
ATC code:N MEDICINES ACTING ON THE NERVOUS SYSTEM; N07 OTHER MEDICINES ACTING ON THE NERVOUS SYSTEM; N07C MEDICINES USED IN VESTIBULARY DISORDERS; N07C A Medicinal products used in vestibular disorders (dizziness); N07C A01 Betahistine
Country of manufacture:Ukraine
Diabetics:Can
Delivery
USPS across the USA USPS across the USA
Canada Post across Canada Canada Post across Canada
Payment
Betahistine-KV tablets 8 mg No. 30
173.85 грн.
Description

Betahistine-KV tablets are prescribed for the following indications:

Meniere's disease and syndrome, which are characterized by three main symptoms: dizziness, sometimes accompanied by nausea and vomiting; hearing loss (deafness); tinnitus. Symptomatic treatment of vestibular vertigo of various origins.

Composition

Active ingredient: betahistine dihydrochloride;

1 tablet contains betahistine dihydrochloride in terms of 100% substance 8 or 16 or 24 mg;

Excipients: microcrystalline cellulose, mannitol (E 421), colloidal anhydrous silicon dioxide, talc, citric acid monohydrate, stearic acid.

Contraindication

Hypersensitivity to any of the components of the drug. Pheochromocytoma.

Method of application

The daily dose for adults is 24-48 mg, evenly distributed throughout the day.

The dose should be selected individually, depending on the effect. A decrease in symptoms is sometimes observed only after two to three weeks of treatment. The best results are sometimes achieved when taking the drug for several months. There is evidence that prescribing treatment early in the disease prevents its progression and / or hearing loss in the later stages.

Application features

Pregnant women

Betahistine should not be used during pregnancy unless clearly necessary.

Children

Due to insufficient data on safety and efficacy, this medicine is not recommended for use in children (under 18 years of age).

Drivers

Betahistine is indicated for the treatment of Ménière's syndrome, which is characterized by a triad of core symptoms: dizziness, hearing loss, tinnitus, - and for the symptomatic treatment of vestibular vertigo. Both conditions may adversely affect the ability to drive and use machines. Betahistine is known to have no or negligible influence on the ability to drive and use machines.

Overdose

Several cases of drug overdose are known. Some patients experienced mild to moderate symptoms (nausea, drowsiness, abdominal pain) after taking the drug in doses up to 640 mg. More serious complications (convulsions, cardiopulmonary complications) were observed with intentional administration of increased doses of betahistine, especially in combination with overdose of other drugs.

Treatment of overdose should include standard supportive measures.

Side effects

Gastrointestinal: nausea and dyspepsia, minor stomach upset (vomiting, gastrointestinal pain, bloating and flatulence). These side effects usually disappear when the drug is taken with food or after reducing the dose. Nervous system: headache. Immune system: hypersensitivity reactions, such as anaphylaxis. Skin and subcutaneous tissue: hypersensitivity reactions of the skin and subcutaneous tissue, including angioedema, rash, itching and urticaria, have been observed.

Interaction

Since betahistine is a histamine analogue, the interaction of betahistine with antihistamines could theoretically affect the effectiveness of one of these drugs.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf life - 3 years.

Specifications
Characteristics
Active ingredient
Betahistine dihydrochloride
Adults
Can
ATC code
N MEDICINES ACTING ON THE NERVOUS SYSTEM; N07 OTHER MEDICINES ACTING ON THE NERVOUS SYSTEM; N07C MEDICINES USED IN VESTIBULARY DISORDERS; N07C A Medicinal products used in vestibular disorders (dizziness); N07C A01 Betahistine
Country of manufacture
Ukraine
Diabetics
Can
Dosage
8 мг
Drivers
Can
For allergies
With caution
For children
It is impossible.
Form
Tablets
Method of application
Inside, solid
Nursing
Considering the benefit/risk ratio
Pregnant
In case of emergency, as prescribed by a doctor
Primary packaging
blister
Producer
Kyiv Vitamin Plant JSC
Quantity per package
30 pcs
Trade name
Betahistine
Vacation conditions
By prescription
Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.

You are watched
new
Sold out
Medlance plus Universal lancet 1.8mm No. 1
Распродано
0
8.20 грн.
new
Alcarnit solution for injection 200 mg/ml ampoule 5 ml No. 5
In stock
0
597.95 грн.
new
Sage tincture bottle 40 ml
In stock
0
54.15 грн.
new
Dibazol-Darnitsa tablets 20 mg No. 10
In stock
0
57.86 грн.
new
Sold out
Amiokordin tablets 200 mg No. 60
Распродано
0
271.66 грн.
new
Sterile universal lancets Gamma No. 50
In stock
0
240.21 грн.
new
Sagilia tablets 1 mg No. 30
In stock
0
744.32 грн.
new
Sold out
Nifuroxazide capsules 200mg No. 10
Распродано
0
40.40 грн.
new
Lindo pacifier clip рк217 penguin/hare
In stock
0
57.95 грн.
new
Sold out
Rizamigren tablets 10 mg blister No. 3
Распродано
0
167.20 грн.